ABOUT Us TOO New York

Us TOO New York is an independent support group for men with prostate cancer and their families. Us TOO New York offers fellowship, peer counseling, education about treatment options, and discussion of medical alternatives without bias. One of our goals is to foster public awareness of prostate disease. However, we do not endorse or give advice concerning any medical provider, treatment, product or service. For medical advice, please consult the appropriate professionals of your choice.

Us TOO New York is a grassroots, self-help organization created and administered by prostate cancer survivors. Our activities demonstrate care, concern, acceptance and understanding while acknowledging the special needs of prostate cancer patients. A number of treatment options exist for prostate cancer, each of which carries some risks and benefits. Potential physical, psychological and emotional side effects after treatment can be devastating if not addressed.

Us TOO New York meetings provide a forum for medical experts to inform group members about treatment options, after treatment counseling and an opportunity for questions and answers as well as discussion with these experts. By being well informed, men can, along with their doctors, make choices about their treatment with confidence.

Us TOO New York meetings also provide tremendous support and reinforcement through peer discussion groups, where members share issues, opinions, and experiences. Family members are encouraged to attend and can also benefit from support and sharing at these group meetings.

Us TOO New York is a chapter of Us TOO! International, a 501(c)(3) charitable organization founded in 1990 by and for prostate cancer survivors, their families, and men at risk.

 

Steering Committee

ROB DUBLIN
STEVE FLAX
JACK DAVID MARCUS

Board of Advisors

NEIL BANDER, MD
Chaus Professor of Urologic Oncology
NY-Presbyterian Weill Cornell
Medical Center

LES GALLO-SILVER, CSW
Director of Clinical Programs
Cancer Care

AARON KATZ, MD
Chairman of Urology,
Winthrop University Hospital

WM. KEVIN KELLY, DO
Head Genitourinary Oncology
Yale University Cancer Center

HERBERT LEPOR, MD
Chairman of Urology
NYU Medical Center

VICTOR NITTI, MD
Vice Chairman, Department of Urology
NYU Medical Center

PETER SCARDINO, MD
Chair, Department of Surgery
Chief, Urology Service
Memorial Sloan-Kettering
Cancer Center

PETER SCHLEGEL, MD
Chairman, Department of Urology
Urologist-in-Chief
NY-Presbyterian Weill Cornell
Medical Center

MICHAEL ZELEFSKY, MD
Director, Brachytherapy Services
Memorial Sloan-Kettering
Cancer Center